Cargando…
ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT)
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184789/ http://dx.doi.org/10.1016/S1569-1993(22)00281-8 |
| _version_ | 1784724605244538880 |
|---|---|
| author | Braisdell, K. West, N.S. |
| author_facet | Braisdell, K. West, N.S. |
| author_sort | Braisdell, K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9184789 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91847892022-06-10 ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT) Braisdell, K. West, N.S. J Cyst Fibros E-Poster Sessions European Cystic Fibrosis Society. 2022-06 2022-06-10 /pmc/articles/PMC9184789/ http://dx.doi.org/10.1016/S1569-1993(22)00281-8 Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | E-Poster Sessions Braisdell, K. West, N.S. ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT) |
| title | ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT) |
| title_full | ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT) |
| title_fullStr | ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT) |
| title_full_unstemmed | ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT) |
| title_short | ePS1.03 The impact of the COVID-19 lockdown and introduction of precision medication Symkevi and Orkambi on cystic fibrosis patients at Sheffield Children’s NHS Foundation Trust, UK (SCFT) |
| title_sort | eps1.03 the impact of the covid-19 lockdown and introduction of precision medication symkevi and orkambi on cystic fibrosis patients at sheffield children’s nhs foundation trust, uk (scft) |
| topic | E-Poster Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184789/ http://dx.doi.org/10.1016/S1569-1993(22)00281-8 |
| work_keys_str_mv | AT braisdellk eps103theimpactofthecovid19lockdownandintroductionofprecisionmedicationsymkeviandorkambioncysticfibrosispatientsatsheffieldchildrensnhsfoundationtrustukscft AT westns eps103theimpactofthecovid19lockdownandintroductionofprecisionmedicationsymkeviandorkambioncysticfibrosispatientsatsheffieldchildrensnhsfoundationtrustukscft |